Mayinglong Pharmaceutical Group Co Ltd (600993) — Cash Flow Quality Index
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Cash Flow Quality Index of 0.88x as of September 2025. Operating cash flow of CN¥139.20 Million is below net income of CN¥157.79 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Mayinglong Pharmaceutical Group Co Ltd generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Mayinglong Pharmaceutical Group Co Ltd Cash Flow Quality Index (2003–2025)
Historical Cash Flow Quality Index for Mayinglong Pharmaceutical Group Co Ltd across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Mayinglong Pharmaceutical Group Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year earnings quality comparison for Mayinglong Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see market value of Mayinglong Pharmaceutical Group Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.03x | CN¥600.44 Million | CN¥581.49 Million | ▲ +13.8% |
| 2024 | 0.91x | CN¥497.61 Million | CN¥548.30 Million | ▼ -33.4% |
| 2023 | 1.36x | CN¥604.07 Million | CN¥443.25 Million | ▲ +91.5% |
| 2022 | 0.71x | CN¥341.85 Million | CN¥480.31 Million | ▼ -43.5% |
| 2021 | 1.26x | CN¥597.17 Million | CN¥474.05 Million | ▲ +91.7% |
| 2020 | 0.66x | CN¥282.99 Million | CN¥430.64 Million | ▼ -52.8% |
| 2019 | 1.39x | CN¥491.58 Million | CN¥353.40 Million | ▼ -25.7% |
| 2018 | 1.87x | CN¥308.24 Million | CN¥164.56 Million | ▲ +62.4% |
| 2017 | 1.15x | CN¥356.17 Million | CN¥308.85 Million | ▲ +12.1% |
| 2016 | 1.03x | CN¥239.60 Million | CN¥233.00 Million | ▲ +18.6% |
| 2015 | 0.87x | CN¥182.85 Million | CN¥210.94 Million | ▲ +49.2% |
| 2014 | 0.58x | CN¥111.67 Million | CN¥192.27 Million | ▼ -20.6% |
| 2013 | 0.73x | CN¥129.94 Million | CN¥177.68 Million | ▼ -27.6% |
| 2012 | 1.01x | CN¥169.25 Million | CN¥167.49 Million | ▲ +81.1% |
| 2011 | 0.56x | CN¥75.37 Million | CN¥135.03 Million | ▲ +685.3% |
| 2010 | -0.10x | CN¥-11.42 Million | CN¥119.76 Million | ▼ -108.3% |
| 2009 | 1.14x | CN¥216.11 Million | CN¥189.19 Million | ▼ -19.8% |
| 2008 | 1.42x | CN¥102.59 Million | CN¥72.00 Million | ▲ +3217.8% |
| 2007 | 0.04x | CN¥6.49 Million | CN¥151.00 Million | ▼ -95.7% |
| 2006 | 1.00x | CN¥75.27 Million | CN¥75.15 Million | ▲ +5.5% |
| 2005 | 0.95x | CN¥58.43 Million | CN¥61.57 Million | ▼ -10.1% |
| 2004 | 1.06x | CN¥54.19 Million | CN¥51.35 Million | ▼ -38.1% |
| 2003 | 1.70x | CN¥67.52 Million | CN¥39.61 Million | — |